« Back
Home /
Tarloxotinib (bromide)

Tarloxotinib (bromide)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	50 mg
Quantity options	100 mg 10mM/1mL 10 mg 1 mg 25 mg 50 mg 5 mg
Item no.	HY-17632-50mg
Targets	EGFR
CASRN	1636180-98-7
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	TH-4000
Purity	99.26
Product Description	Tarloxotinib bromide (TH-4000) is an irreversible EGFR/HER2 inhibitor.
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	681.77
Clinical_Information	Phase 2
Manufacturers Research Area	Cancer
Solubility	DMSO : ≥ 33 mg/mL
Manufacturers Target	EGFR
Isoform	ErbB2/HER2
Pathway	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-17632-50mg-safety-datasheet.pdf